Contact
Please use this form to send email to PR contact of this press release:
Vidac Pharma Secures U.S. Patent Protection for Mitochondria-Targeted Cancer Therapy
TO:
Max Herzberg
Vidac pharma Holding Plc
+972 54-425-7381